Technology Prognosis

tracking technologies before you have to make a decision

Polivy (Polatuzumab Vedotin-piiq) for Diffuse Large B-Cell Lymphoma

June 12, 2019

Polivy (polituzumab-vedotin-piiq) is an intravenously administered CD79b-directed antibody-drug conjugate indicated in combination with a rituximab product and bendamustine for adult patients with relapsed/refractory diffuse large B-cell lymphoma after at least 2 prior therapies.